Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDillistone Regulatory News (DSG)

Share Price Information for Dillistone (DSG)

Share Price is delayed by 15 minutes
Get Live Data
11.50    0.00 (0.00%)
Bid:
11.00
Ask:
12.00
Spread: 1.00 (9.091%)
Market Cap: £4.07m
DSG Live PriceLast checked at - London Stock Exchange

Intraday Dillistone Share Chart

Exercise of Options

5 May 2009 15:06

RNS Number : 7018R
Dillistone Group PLC
05 May 2009
 



5 May 2009

Dillistone Group Plc

("Dillistone" or the "Company")

Exercise of Options

Dillistone, the AIM quoted supplier of recruitment software, announces that application has been made for the admission of new ordinary shares of 5 pence each in the share capital of Dillistone ("Ordinary Shares") to trading on AIM following the exercise, on 5 May 2009 by employees, of share options granted on 3 May 2006 under the Company's share option schemes ("Share Options"). The exercise price of the Share Options was 16.154 pence per Ordinary Share.

These new Ordinary Shares will rank pari passu with all existing Ordinary Shares and it is expected that dealing in the new Ordinary Shares will commence on 11 May 2009.

37,143 of the Share Options exercised were exercised by Alexander James, Projects Director of Dillistone. Following this option exercise Alexander James is now beneficially interested in 40,498 Ordinary Shares which represents approximately 0.72 per cent. of the enlarged issued share capital of the Company following the exercise of the Share Options ("Enlarged Share Capital").

In addition, Dillistone was notified today that Mike Love, Non-Executive Director of Dillistone and Executive Directors Jason Starr, Jim McLaughlin and Rory Howard all purchased Ordinary Shares on 5 May 2009 at 130 pence per Ordinary Share as set out in the table below:- 

Director

Number of Ordinary Shares purchased

Ordinary Shares held prior to purchase

Ordinary Shares held following purchase

Number

% of existing issued share capital

Number

% of Enlarged Share Capital

Mike Love

nil

nil

%

Jason Starr

1,172,461

21.71%

%

Jim McLaughlin

1,000,000

18.52%

%

Rory Howard

1,162,461

21.53%

%

For the purposes of the Financial Services Authority's Disclosure and Transparency Rules, the total number of Ordinary Shares in issue at today's date is  with each Ordinary Share holding one voting right. There are no Ordinary Shares held in treasury.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules. 

For further enquiries:

Jim McLaughlin, Finance Director and Executive Chairman Dillistone Group Plc

01934 710 509

Emily Morgan, Blomfield Corporate Finance Limited

0207 489 4500

Daniel Briggs, Religare Hichens, Harrison

0207 3827 776

Tom Cooper, Winningtons Financial PR

0797 122 1972

Notes to Editors:

Dillistone Group Plc is a leader in the supply and support of recruitment software to the search and selection market. Dillistone was admitted to AIM, a market operated by the London Stock Exchange plc in June 2006.

Dillistone develops, publishes and supports Filefinder, its executive recruitment software, for recruitment companies and in-house recruitment teams. Filefinder is unique in providing tailored workflow and 24 hour support for global users, to mirror the profile and demands of an executive search assignment. Filefinder has been adopted by around 1,000 companies in more than 55 countries.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEADSSESPNEFE
Date   Source Headline
7th May 20267:00 amRNSFinal Results & Investor Presentation
24th Apr 20267:00 amRNSNotice of Final Results & Investor Presentation
9th Mar 20262:44 pmRNSHolding(s) in Company
9th Mar 20262:44 pmRNSHolding(s) in Company
9th Mar 20262:23 pmRNSHolding(s) in Company
9th Mar 20262:23 pmRNSHolding(s) in Company
2nd Mar 20263:08 pmRNSHolding(s) in Company
25th Feb 202611:40 amRNSHolding(s) in Company
25th Feb 202610:09 amRNSHolding(s) in Company
23rd Feb 20262:28 pmRNSResult of GM & Directorate Change
11th Feb 202612:59 pmRNSHolding(s) in Company
5th Feb 202611:28 amRNSResult of Placing and Subscription
4th Feb 20264:47 pmRNSProposed Placing and Subscription
30th Sep 20257:00 amRNSInterim Results & Investor Presentation
11th Sep 20257:00 amRNSNotice of Interim Results & Investor Presentation
4th Jun 202511:50 amRNSResult of AGM
4th Jun 20257:01 amRNSAGM Statement
4th Jun 20257:00 amRNSRelated party loan
9th May 202511:32 amRNSDirectorate Declaration
8th Apr 20257:00 amRNSFinal Results & Investor Presentation
3rd Apr 20257:00 amRNSNotice of Results & Investor Presentation
5th Feb 20257:00 amRNSTrading Update & Notice of Results
4th Dec 20247:00 amRNS-ROpenAI powered Interview Simulation Platform
17th Sep 20247:00 amRNSInterim Results & Investor Presentation
11th Sep 20247:00 amRNSNotice of Results & Investor Presentation
2nd Sep 20249:45 amRNSHolding(s) in Company
29th Aug 20248:30 amRNSHolding(s) in Company
23rd Aug 20247:00 amRNSTrading update and Fund Raising
15th Jul 20247:00 amRNSChange of Adviser
12th Jun 20241:40 pmRNSResult of AGM
12th Jun 20247:00 amRNSAGM Statement
25th Apr 20247:00 amRNSFinal Results & Investor Presentation
22nd Apr 20247:00 amRNSNotice of Results & Investor Presentation
9th Apr 20247:00 amRNSBlock listing Interim Review
30th Jan 20247:00 amRNSTrading Update & Notice of Results
9th Oct 20237:00 amRNSBlock listing Interim Review
26th Sep 20237:00 amRNSInterim Results & Investor Presentations
18th Sep 20237:00 amRNSNotice of Results & Investor Presentations
13th Jun 20231:18 pmRNSResult of AGM
13th Jun 20237:00 amRNSAGM Statement
25th Apr 20237:00 amRNSFinal Results & Investor Presentation
11th Apr 20237:00 amRNSBlock listing Interim Review
30th Mar 20237:00 amRNSContract & Notice of Results
2nd Feb 20237:00 amRNSTrading Update & Notice of Results
7th Nov 20227:00 amRNSDirector Dealings
10th Oct 20227:00 amRNSBlock listing Interim Review
26th Sep 20227:01 amRNSDirectorate Changes
26th Sep 20227:00 amRNSInterim Results & Investor Presentation
20th Sep 20227:00 amRNSNotice of Results & Investor Presentation
16th Jun 20228:00 amRNSIssue of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.